what about prevention of bioterrorism? >> i will comment that there is a strong network throughout the united states and we really partnered with local and state health departments. it starts with an astute clinician. someone who recognizes there is something odd. characteristic of a possible bioterrorism related pathogen. once that decision or clinician alerts the local health department, they can sometimes do the rapid testing locally. the cdc is often involved at an early stage. >> one of the reasons that we do sendingrian efforts, staff to investigate ebola outbreaks is that there is still a lot to learn about it. the event it is used as a bioterrorism agent, the cdc is involved in research that helps us establish whether there are vaccine candidates and all sorts of things in the hopes of better preparing us for something. is the mostk ebola likely agent of bioterrorism. it doesn't last very long in the environment is my understanding. the ideal agent is a little more long-lived than ebola. import, play, to or work wi

what about prevention of bioterrorism? >> i will comment that there is a strong network throughout the united states and we really partnered with local and state health departments. it starts with an astute clinician. someone who recognizes there is something odd. characteristic of a possible bioterrorism related pathogen. once that decision or clinician alerts the local health department, they can sometimes do the rapid testing locally. the cdc is often involved at an early stage. >> one of the reasons that we do humanitarian efforts, sending staff to investigate ebola outbreaks is that there is still a lot to learn about it. in the event it is used as a bioterrorism agent, the cdc is involved in research that helps us establish whether there are vaccine candidates and all sorts of things in the hopes of better preparing us for something. i don't think ebola is the most likely agent of bioterrorism. it doesn't last very long in the environment is my understanding. the ideal agent is a little more long-lived than ebola. >>

the money put toward ebola research is bioterror. it might be a bioterror weapon in some way. but the money given to these vaccines in research is a tiny step. you would need tens of millions of dollars for a treatment spread throughout africa and that's unlikely to happen. >> jake, didn't you ask the experts, wouldn't it be worth a try to give people the vaccine? >> when you talk to experts about it, they have mixed views about t anybody sick on the bed with ebola would accept this into their body. but when you talk from an epidemiological perspective, with ebola, you don't know how people are going to behave. if they touch the dead, or they come into contact with one another, thing they are cured and they're not. and trials in an emergency situation are not a good way to develop a scientific and reliable vaccine. >> tomorrow, the american soldier freed after years of captivity in afghanistan, faces questions from the u.s. army. army associate, bowe bergdahl, abandoned his post. and he was captured by the taliban and released in may as part of a prisoner swap. >>> what's comi

so the little money being thrown at have come from military money, mostly as fighting ebola as a bioterror threat. but it's not enough to be a widely available vaccine. >> is there a chance that they're treading with a drug in the united states, and there's a canadian company, a publicly traded company, and a single drug company. is there a chance that these are real drugs. >> it's perfectly possible that this could be happening, and everyone is excited to say it's a miracle cure. but we'll never know. the drugs that they were given have only been tested in primates, only eight monkeys in total. and until you set up a control group, you never know. it looks promising and it would be exciting if it worked but no one wants to throw the money at this, aside from a little bit of bioterror money. to make a leap and spread it around in africa like you would need to. >> jake, we're getting ahold of russian hackers who got ahold of 1.2 billion passwords from major companies, and what do you know about this? >> it was companies in kazakhstan, they know each other personally or have a club where the

these labs are critical to our nation's response to bioterrorism threats. so i am interested in learning about how this moratorium and the lab closures are affecting the critical research these labs were conducting. dr. frieden, how did the moratorium and lab closures limit cdc's research capabilities? what happens to the studies, some of which i'm guessing were operating on detailed schedules that were being conducted in the labs. >> we're looking at the moratorium in detail and identifying any laboratories which need to resume transfers for individual patient care or for public health response with highest priority. and we expect that those laboratories we will be able to get reopened for transfer very soon. but we've already heard from, for example, the laboratory that deals with drug resistant tuberculosis, the lab that deals with ebola and the labortory that deals with avian influenza that they have deadlines coming up for either patient care or public health response, and we will address that very quickly, but we will always put safety first. >> how d

worry ebola could be used in a bioterror attack. u.s. studies have been promising. he said right now real world testing is what patients need. >> see where we can offer that to people suffering from an infection with up to 90% mortality. >> the stakes have never been higher. for the first time, the virus spreading across borders. >> it's far more difficult to control ebola when you go into the big cities, far more difficult to trace all the contacts, to isolate people. >> until scientists find a cure, doctors will keep struggling as ebola keeps killing. will ripley, cnn, london. >> and of course it is very serious, but we should let people know there are a lot of people working hard to contain it and to stop it from spreading, so not to fear too much. >> the cdc sending 50 more experts over there. >> when we return, we'll update you on the crisis in gaza. >>> after a break, our exclusive interview with the hamas leader. >> what are you prepared to do to get a ceasefire? are you prepared to destroy your tunnels? are you prepared to stop firing rockets at israel? are

have that have arisen mainly out of funding from governments, we should aim particularly to meet bioterrorism threats. people are worried that ebola virus could be used in germ warfare. >> according to "the washington post" in 2010, the u.s. department of defense signed a $140 million contract with the company to develop a treatment for ebola infections, a research program aimed at enhancing the nation's bio defense capability -- biodefense response capability. >> let's bring you the news coming in from the middle east. the israeli police sources say that a rocket has landed just two hours before the end of the temporary cease-fire. negotiations are going on in cairo between israel and hamas mediated by egypt, in order to try to find a solution to the conflict which has claimed almost 2000 lives in the gaza strip. the latest coming in from the middle east is from israeli police forces, saying that a rocket has landed on israel ahead of that truce deadline. with no solution it seems on the table at the talks in cairo, it seems that the resumption of hostilities, as threatened by both sides, lo

the military and the defense regimes are certainly aware of this agent as a possible agent of bioterrorism and they're working on methods to control it. >> still, the challenges on the ground go way beyond prevention and cure. >> then we have the major issue of the zs trust in liberia, in sierra leone, particularly also. the government and health services. some people have even accused western doctors to come there to experiment on people. we have to deal with that as well. >> the most effective way to stop the spread of ebola at the moment, is early diagnosis and quick isolation of those infected. not an easy task in countries where the health care system is already broken or nonexistent. jim bolden, cnn, london. >> hopefully this will be the time there are some breakthroughs in learning how to treat ebola. >> the serum is hopeful, it could mean something, the fight continues. still to come for you here on cnn, japan is bracing right now for more torrential rain, we'll bring you an update on when a dangerous typhoon could make landfall. so this board gives me rates so this board gives me

it is so deadly that it is deemed a category a bioterrorism agent.nited states department of defense that funds research to finding a cure. there is no known cure as yet. the who is asking for $100 million to put more nurses and doctors on the ground. all they can really do is help you and give you fluids and some sort of and about except hope owneuro owner -- your immune system will fight off the virus. only 10,000 people have ever died from this virus. it was discovered on the banks of the ebola river about 40 years ago. they are helping a sudden development -- certain drug development. company thatpanese has a chemical unit that is developing a virus prevention for the influenza violence. there are antibody cocktails being developed. these are very small pharmaceutical companies being supplied with money by $28 million grants here. this is very small fry you think of the billions that have been poured into tackle hiv or finding drugs to cure that virus. >> we were talking to a guest earlier. in urban areas in these countries you don't really feel

category ad a bioterrorism agent. it is used as a lethal weapon. there is no cure.st not commercially viable. it was found on the banks of the ebola river. less than 10,000 people who actually died. the big drug companies, the numbers don't add up. we have small pharmaceutical companies being helped when the ..s. government to dispense the defense department is adding $140 million to a company that is helping develop the drug. they have had the first human trial back in january. other small drug companies are helping. there is a drug company in tokyo. on the back of that they found it also helps to tackle ibo. there is a swiss vaccine company that is helping. so far, there is no breakthrough. it there are two key cancer --gs that seem to help the fight the virus. there is no key to her. the numbers don't add up for the bigger drug companies. is helping totes supply and the world health organization hoping to raise $100 million to get more doctors into africa to help fight at the moment. >> let's talk about how this is affecting a business. it many of these economies

and doctor friedman, who was so upset about the safety lapses at the bioterror rapid response lab was there today reassureing people, we know how to deal with ebola, we are sending more people over to the hot zone, when these patients come back. they will go directly to special isolation unit, east of here, the cdc will not be involved in the patient care, emory is confident they can take care of the patients with utmost caution, concern and care. lou: john thank you, john roberts appreciate it. >> we're coming right back stay with us. lou: republicans suing the president, lis wiehl, and mercedes cold win on that, and what happens when a president refuses to enforce the law? when folks think about what they get from alaska, they think salmon and energy. but the energy bp produces up here creates something else as well: jobs all over america. engineering and innovation jobs. advanced safety systems & technology. shipping and manufacturing. across the united states, bp supports more than a quarter million jobs. when we set up operation in one part of the country, people in other parts g

the names of the labs are being kept secret because of federal bioterrorism laws.ooks at the drought in the west. as we have been showing you california is the hardest hits. some areas haven't had substantial rain in three years. nearly 60% of the state is officially in an exceptional drought condition. that's the worst category. there is no relief the in sight. aquifers are the usual backup source. they are being pumped at unsustainable rates. i live in los angeles. man, we miss the rain. it's crazy dry out there snk britain's "guardian" says julian assange will leave his safehouse but they won't say when or why. >> we can confirm that i am leaving the embassy soon. but perhaps not for the reasons that the murdoch press and sky news say. >> reporter: assange has been staying at the embassy of ecuador in london for two years. he told reporters his health has suffered. swedish investigators want to question him over sexual assault allegations. u.s. authorities want to talk to him about the leak of confidential hill tear document hs this 2010. >>> finally, wall stree

in this case they have thrown money at it when they were worried that this could be a bioterror weapon. it will not make the $10 million leap to get into the private market. >> that speaks volumes >>> a new york hospital will know if one of its patients has ebola. mt sinai quarantined a man that visited last month. the doctor said it is not likely that he has ebola. test results are expected this week. the ukranian military is pushing ahead with an offensive to take back rebel-held territory. government forces fought 26 tombs over the past -- times over the past 26 hours. these images show the damage caused by the ongoing assault. ukraine is worried about russian military exercises conducted across the border. tens of thousands of troops have been moved to reason miles of ukraine. the u.n. says more than 117,000 people have been forced to fully eastern ukraine because of the fighting. the president says it has taken three-quarters of rebel-held territory back. securing the region is difficult. we have this report from outside donetsk. >> reporter: this family walks to safety. they are

the military and the defense regimes certainly are aware of this agent as a possible agent of bioterrorism and are working on methods to control it. >> reporter: still, the challenges on the ground go way beyond prevention and cure. >> and we have the major issue of, you know, the distrust in liberia, in sierra leone, particularly also the government in health services. some people have even accused western doctors to come there to experiment on people, so we have to deal with that as well. >> reporter: the most effective way to stop the spread of ebola at the moment is early diagnosis and quick isolation of those infected. not an easy task in countries where the health care system is already broken or nonexistent. jim bolden, cnn, london. >>> still to come, as ukraine's military closes in, residents going underground. the stories of fear and suffering after the break. every day, people fall. from a simple misstep, to tripping over a rug, to just losing their balance. and not being able to get up from a fall can have serious, lifetime consequences. being prepared is important. philips life

to me, that is a better use of them, to use them to fight ebola , the bioterrorism money -- i mean, itsilly and away, right, but it is a better use of it, in my view. can, we mention, if i do have partners in both liberia and sierra leone. partners and partners in health. and we are sending people the other way. they arson in people the other -- they arewith the sending people the other way to help with the epidemic. one of them is called will body alliance, the one and sierra leone. the other one has a name there were talking about, which is last mile health. there talking about going the last mile to serve the world poor. i think the congressmen who were quoted, it would be great if they could pay attention to that part of it. we should work harder to serve poor people come especially kids . >> there's a front-page article in "new york times" today with the headline of the article -- it is talking about it being a model. it talks about a place in new jersey, actually. this is a picture of your clinic and rwanda? >> it is a hospital, actually. partners in health built it for the publi

category a bioterrorism agent as well. this is who is supplying the money to try and find a cure. it is u.s. government supplying the money. tiny bits of money. they have the u.s. defense department giving $140 million to a small pharmaceuticals company. hopefully they are going to find some sort of treatment. there is a japanese company working on a treatment. they were looking on a drug to fight influenza. you have other small pharmaceuticals. one is a swiss company. there are vaccines developed but very slowly. as the man said on that film, it is not commercially viable for large drug companies. there aren't enough people dying. >> some of these villages the distrust of government is so high they are pushing back against getting more help. is one question on my mind the business impact. right now it seems minimal. had the emirates stop some flights to ginny. they are saying so far they could be affected. mining companies say they are ok for the time being. >> we will be back in two. ♪ . >> welcome back to "on the move." i am jon ferro. joining you from europe's headquarters wit

it suggested using grenades to help disperse the bioterror and targeted closed areas like stadiums and subways where people would be trapped. let's turn to cnn terrorism analyst paul cruickshank on the phone with me. >> good morning, carol. >> paul, how likely is it isis could successfully carry out a biological attack? >> obviously this news has caused a concern and this guy was a chemistry graduate but there's a different between aspiring to make these sorts of weapons and having any capability. al qaeda for example had researched this kind of stuff for the last couple of decades but they've never come close to developing biological or chemical weapons. the distribution systems for these kind of things particularly are difficult but what's also concerning now is that we're kind of in unchartered territory with isis because they control a large degree of territory, and also they have deep financial pockets, they're raising millions of dollars a day and they're also attracting foreign fighters from across the middle east. now the worry is that some of those could have scientific knowle

so how will cdc address bioterrorism or other emergencies that might occur before they reopen? >> there's just one particular laboratory that is shut. there are multiple other laboratories at cdc that continue operation that would be able to respond to bioterrorist incidents. >> okay. there's no concern on your part because of the cdc errors we may be limiting our ability to protect the public? >> no, i'm confident that the incidents we saw did not cause any release of agents into the community. they most likely did not cause any actual exposure to cdc staff, but they really are a tipping point in our effort to recognize we need to improve our safety. but we're still fully functional in terms of being able to respond to an event. it's just that step of sending something out of a high containment space into a low containment space that i've issued a moratorium on. and we'll lift that laboratory by laboratory as soon as we're confident we can do that safely. >> okay. is the cdc planning on using the nashlg national science advisory board for biosecurity to advise cdc on laborator